Reaction

Polycystic Liver Disease reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 106 reports · 5 co-occurring drugs

As of the last recalculation, Polycystic Liver Disease appears in 106 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 286.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Febuxostat Tablets 40 Mg	13	286.0	286.3
Febuxostat Tablets 80 Mg	13	286.0	286.3
Tolvaptan	15	235.9	236.2
Febuxostat	13	173.5	173.6
Pazopanib Hydrochloride	13	107.4	107.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.